Abstract
BackgroundRituximab (RTX) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Originally developed for the treatment of B-cell non-Hodgkin’s lymphoma,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have